PTHrP, A Biomarker for CNS Metastasis in Triple-Negative Breast Cancer and Selection for Adjuvant Chemotherapy in Node-Negative Disease.
Gloria AssakerAnne CamirandBassam AbdulkarimAtilla OmerogluJean DeschenesKurian JosephAbu Shadat Mohammod NomanAgnihotram V Ramana KumarRichard KremerSiham SabriPublished in: JNCI cancer spectrum (2019)
PTHrP is a novel independent prognostic factor for CNS metastasis and adjuvant chemotherapy selection of low-clinical risk node-negative TNBC. Its predictive value needs to be prospectively assessed in clinical trials.